Wysa

Wysa is a conversational AI for mental-health support — a clinically validated, CBT-based (cognitive behavioral therapy) chat assistant designed to provide self-guided support for anxiety, depression, stress, and related conditions. Founded in 2015 by Jo Aggarwal and Ramakant Vempati in Bangalore (with US headquarters in Boston), the company has raised approximately $30 million across multiple funding rounds and remains privately held.

Wysa's product is delivered as a chat-based mobile and web application accessible directly to consumers (over 6 million users worldwide across 95 countries) and through B2B and B2B2C partnerships with employers, health plans, and government health systems. The chatbot uses evidence-based therapeutic techniques — CBT, dialectical behavior therapy (DBT), mindfulness, and motivational interviewing — and is supplemented by access to human coaches for users with paid or sponsored access. Importantly, Wysa is positioned as a self-help tool, not a clinical-grade therapy replacement; users in crisis are routed to human support.

Major B2B partners include Aetna, Cigna, Astra Zeneca, BSE (formerly Bombay Stock Exchange), and several Fortune 500 employers. Wysa is the official mental-wellness platform for the UK NHS's North London Health Plan, and has been deployed across multiple state-level mental health systems in India. The product holds FDA Breakthrough Device designation for adolescent depression. Wysa has been rated effective in over 15 peer-reviewed clinical studies and remains one of the most-cited mental-health chatbots in academic literature, supporting its evidence-based positioning against newer entrants in the space.